Výsledky vyhledávání

Akademický článek

First-line Avelumab plus Chemotherapy in Patients with Advanced Solid Tumors: Results from the Phase Ib/II JAVELIN Chemotherapy Medley Study.

Autor: Wheatley DA; Royal Cornwall Hospital, Treliske, Truro, United Kingdom., Berardi R; AOU delle Marche, Università Politecnica delle Marche, Ancona, Italy., Climent Duran MA; Instituto Valenciano de Oncología, Valencia, Spain., Tomiak A; Kingston Health Sciences Centre, Kingston, Ontario, Canada., Greystoke AP; NU Cancer, Newcastle University, Newcastle upon Tyne, United Kingdom., Joshua AM; St Vincent's Hospital Sydney, Darlinghurst, New South Wales, Australia., Arkenau HT; Sarah Cannon Research Institute, HCA Healthcare, London, United Kingdom., Géczi L; National Institute of Oncology, Budapest, Hungary., Corbacho JG; Clinic Institute of Hematological and Oncological Diseases, Hospital Clinic, Barcelona, Spain., Paz-Ares LG; Hospital Universitario 12 de Octubre, Madrid, Spain., Hussain SA; Weston Park Hospital, University of Sheffield, Sheffield, United Kingdom., Petruželka L; General University Hospital in Prague, Prague, Czech Republic., Delmonte A; IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori,' Meldola, Italy., Chappey C; Pfizer, San Francisco, California., Masters JC; Pfizer, San Diego, California., Michelon E; Pfizer, New York, New York., Murphy DA; Pfizer, San Diego, California., Mwewa S; Pfizer, Paris, France., Cesari R; Pfizer, Milan, Italy., Doger de Spéville B; Fundación Jiménez Díaz University Hospital, Madrid, Spain.

Publikováno v: Cancer research communications [Cancer Res Commun] 2024 Jun 28; Vol. 4 (6), pp. 1609-1619.

Zobrazit plný text záznamu

Akademický článek

Upper Aerodigestive Tract Endoscopy Combining Rigid Laryngoscopy and Flexible Endoscopy.

Autor: Dubray-Vautrin A; Department of Oto-Rhino-Laryngology, Head & Neck Surgery, Institut Curie, Paris, France.; Departement of Oto-Rhino-Laryngology, Head & Neck Surgery, Institut Curie, Saint-Cloud, France., Chappey C; Departement of Oto-Rhino-Laryngology, Head & Neck Surgery, Institut Curie, Saint-Cloud, France., Taouachi R; Departement of Oto-Rhino-Laryngology, Head & Neck Surgery, Institut Curie, Saint-Cloud, France., Ghanem W; Department of Oto-Rhino-Laryngology, Head & Neck Surgery, Institut Curie, Paris, France., Choussy O; Department of Oto-Rhino-Laryngology, Head & Neck Surgery, Institut Curie, Paris, France.; Departement of Oto-Rhino-Laryngology, Head & Neck Surgery, Institut Curie, Saint-Cloud, France.

Publikováno v: Surgical innovation [Surg Innov] 2024 Jun; Vol. 31 (3), pp. 229-232. Date of Electronic Publication: 2024 Mar 06.

Zobrazit plný text záznamu

Avelumab Plus Talazoparib in Patients With BRCA1/2- or ATM-Altered Advanced Solid Tumors: Results From JAVELIN BRCA/ATM, an Open-Label, Multicenter, Phase 2b, Tumor-Agnostic Trial

ImportanceNonclinical studies suggest that the combination of poly(ADP-ribose) polymerase and programmed cell death 1/programmed cell death–ligand 1 inhibitors has enhanced antitumor activity; however, the patient populations that may benefit from

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e4a524244c00c77d72380a7c586fc63
https://hdl.handle.net/10807/232628

Zobrazit plný text záznamu

Akademický článek

Barrier properties of polyamide 12/montmorillonite nanocomposites: Effect of clay structure and mixing conditions

Autor: Follain, N., Alexandre, B., Chappey, C., Colasse, L., Médéric, P., Marais, S.

Publikováno v: In Composites Science and Technology 18 November 2016 136:18-28

Zobrazit plný text záznamu

Akademický článek

Study of water sorption on modified Agave fibres

Autor: Bessadok, A., Langevin, D., Gouanvé, F., Chappey, C., Roudesli, S., Marais, S.

Publikováno v: In Carbohydrate Polymers 2009 76(1):74-85

Zobrazit plný text záznamu

Akademický článek

Enhanced water and oxygen barrier performance of flexible polyurethane membranes for biomedical application.

Autor: Marcano A; Normandie Université, UNIROUEN, INSA ROUEN, CNRS, Polymères Biopolymères Surfaces (PBS), Rouen, France.; CARMAT SA, Vélizy Villacoublay, France., Fatyeyeva K; Normandie Université, UNIROUEN, INSA ROUEN, CNRS, Polymères Biopolymères Surfaces (PBS), Rouen, France., Koun M; ALTEN, Boulogne-Billancourt, France., Dubuis P; INOPROD, Cournon D'Auvergne, France., Grimme M; CARMAT SA, Vélizy Villacoublay, France., Chappey C; Normandie Université, UNIROUEN, INSA ROUEN, CNRS, Polymères Biopolymères Surfaces (PBS), Rouen, France., Marais S; Normandie Université, UNIROUEN, INSA ROUEN, CNRS, Polymères Biopolymères Surfaces (PBS), Rouen, France.

Publikováno v: Journal of biomedical materials research. Part A [J Biomed Mater Res A] 2022 Jan; Vol. 110 (1), pp. 105-121. Date of Electronic Publication: 2021 Jul 20.

Zobrazit plný text záznamu

Akademický článek

Avelumab Plus Talazoparib in Patients With Advanced Solid Tumors: The JAVELIN PARP Medley Nonrandomized Controlled Trial.

Autor: Yap TA; The University of Texas MD Anderson Cancer Center, Houston., Bardia A; Massachusetts General Hospital, Boston., Dvorkin M; Clinical Oncology Dispensary, Budget Healthcare Institution of Omsk Region, Omsk, Russian Federation., Galsky MD; Icahn School of Medicine at Mount Sinai, New York, New York., Beck JT; Highlands Oncology Group, Springdale, Arkansas., Wise DR; NYU Laura and Isaac Perlmutter Cancer Center, New York, New York., Karyakin O; Medical Radiological Research Center, Kaluga, Russian Federation., Rubovszky G; National Institute of Oncology, Budapest, Hungary., Kislov N; Yaroslavl Regional Cancer Hospital, Yaroslavl, Russian Federation., Rohrberg K; Department of Oncology, Phase I Unit, Rigshospitalet, Copenhagen, Denmark., Joy AA; Cross Cancer Institute, Department of Oncology, University of Alberta, Edmonton, Canada., Telli ML; Stanford University School of Medicine, Stanford, California., Schram AM; Memorial Sloan Kettering Cancer Center, New York, New York., Conte U; Pfizer, New York, New York., Chappey C; Pfizer, San Francisco, California., Stewart R; Now with Translational Medicine, Oncology at AstraZeneca, Cambridge, United Kingdom.; Pfizer, San Diego, California., Stypinski D; Pfizer, San Diego, California., Michelon E; Pfizer, New York, New York., Cesari R; Pfizer, Milan, Italy., Konstantinopoulos PA; Dana-Farber Cancer Institute, Boston, Massachusetts.

Publikováno v: JAMA oncology [JAMA Oncol] 2023 Jan 01; Vol. 9 (1), pp. 40-50.

Zobrazit plný text záznamu

Akademický článek

Avelumab Plus Talazoparib in Patients With BRCA1/2- or ATM-Altered Advanced Solid Tumors: Results From JAVELIN BRCA/ATM, an Open-Label, Multicenter, Phase 2b, Tumor-Agnostic Trial.

Autor: Schram AM; Memorial Sloan Kettering Cancer Center, New York, New York., Colombo N; University of Milan-Bicocca and Istituto Europeo di Oncologia, IRCCS, Milan, Italy., Arrowsmith E; Tennessee Oncology/Sarah Cannon Research Institute, Chattanooga., Narayan V; Abramson Cancer Center, University of Pennsylvania, Perelman School of Medicine, Philadelphia., Yonemori K; National Cancer Center Hospital, Chuo-ku, Tokyo, Japan., Scambia G; Gynecologic Oncology Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy., Zelnak A; Northside Hospital Inc, Atlanta, Georgia., Bauer TM; Tennessee Oncology/Sarah Cannon Research Institute, Nashville., Jin N; Division of Medical Oncology, Wexner Medical Center, The Ohio State University, Columbus., Ulahannan SV; Stephenson Cancer Center, Oklahoma City, Oklahoma., Colleoni M; Division of Medical Senology, European Institute of Oncology, IRCCS, Milan, Italy., Aftimos P; Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium., Donoghue MTA; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York., Rosen E; Memorial Sloan Kettering Cancer Center, New York, New York., Rudneva VA; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York., Telli ML; Stanford University School of Medicine, Stanford, California., Domchek SM; Basser Center for BRCA , Abramson Cancer Center, University of Pennsylvania, Philadelphia., Galsky MD; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York., Hoyle M; Pfizer, Milan, Italy., Chappey C; Pfizer, San Francisco, California., Stewart R; now with Translational Medicine, Oncology at AstraZeneca, Cambridge, England, United Kingdom.; Pfizer, San Diego, California., Blake-Haskins JA; Pfizer, La Jolla, California., Yap TA; The University of Texas MD Anderson Cancer Center, Houston.

Publikováno v: JAMA oncology [JAMA Oncol] 2023 Jan 01; Vol. 9 (1), pp. 29-39.

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání